echistatin has been researched along with glycyl-arginyl-glycyl-aspartyl-seryl-proline* in 3 studies
1 review(s) available for echistatin and glycyl-arginyl-glycyl-aspartyl-seryl-proline
Article | Year |
---|---|
Integrin-dependent mobilization of intracellular calcium ions in osteoclasts. A possible role in the regulation of the secretion of protons and lysosomal enzymes.
Topics: Amino Acid Sequence; Animals; Calcium; Cell Nucleus; Exocytosis; Homeostasis; Integrins; Intercellular Signaling Peptides and Proteins; Intracellular Fluid; Lysosomes; Molecular Sequence Data; Oligopeptides; Osteoclasts; Peptides; Rats; Viper Venoms | 1994 |
2 other study(ies) available for echistatin and glycyl-arginyl-glycyl-aspartyl-seryl-proline
Article | Year |
---|---|
Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction.
Platelet interaction with endothelium plays an important role in the pathophysiology of coronary microcirculation. We assessed the role of the vitronectin receptor (integrin alpha(v)beta3) in platelet/endothelium adhesion.. We investigated the effect on platelet/endothelium adhesion of plasma obtained from patients with acute myocardial infarction during reperfusion (before and 8, 24, 48, and 72 hours and 5 to 7 days after direct angioplasty) and with pretreatment with alpha-thrombin (2 U/mL) and recombinant human interleukin-1beta. Platelet/endothelium adhesion was significantly enhanced by approximately 20% after pretreatment of endothelium with patient plasma for 4 hours (P<.05) compared with endothelium treated with pooled control plasma. Plasma-induced platelet/endothelium adhesion was, in part, RGD peptide dependent. Pretreatment of endothelial cells with alpha-thrombin or recombinant human interleukin-1beta enhanced platelet/endothelium adhesion and surface expression of alpha(v)beta3 on the luminal aspect of endothelium (P<.05). The adhesion of platelets, isolated platelet microparticles, and Chinese hamster ovary cells bearing human recombinant alpha(IIb)beta3 (platelet glycoprotein IIb-IIIa) to activated endothelial cells was inhibited by antiadhesive peptides GRGDSP and c(RGDfV) and monoclonal antibodies 4F10, LM609, and 7E3.. The expression of vitronectin receptor exposed on the luminal aspect of activated endothelium is enhanced and mediates platelet/endothelium adhesion. Vitronectin receptor-mediated platelet attachment to activated endothelium during reperfusion may contribute to reperfusion injury and could be a target for antiadhesive therapy. Topics: Adult; Aged; Animals; Antigens, Surface; Blood Proteins; Cell Adhesion; Cells, Cultured; CHO Cells; Cricetinae; Endothelium, Vascular; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Microscopy, Electron; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Oligopeptides; Peptides; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Vitronectin; Recombinant Proteins; Umbilical Veins | 1997 |
Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
We investigated possible inhibitory effects of five synthetic Arg-Gly-Asp (RGD)-containing peptides on osteoclastic resorption in three distinct in vitro resorption assays (17-day-old fetal mouse bone organ cultures) that differ in stages of osteoclast differentiation. RGD peptides, which can bind the adhesion receptors called integrins, inhibited osteoclastic resorption (45Ca release) in fetal mouse bone explants in which osteoclast precursors have yet to adhere to the mineralized matrix and develop into mature osteoclasts (metacarpals and coculture system). Treatment of metacarpals with RGD peptides inhibited the formation of multinucleated TRAP+ osteoclasts in the mineralized matrix because their mononuclear TRAP+ osteoclast precursors remained localized in the periosteum. In particular, echistatin, a viper venom protein with known affinity for alpha v beta 3 integrin, and GdRGDSP inhibited osteoclastic resorption dose dependently in these systems (ED50 10(-9) and 10(-4) M, respectively) but did not alter the activity of mature resorbing osteoclasts in radii. In addition, 45Ca release was significantly inhibited by the cyclic peptide GPenGRGDSPCA, which has a relatively higher affinity for the vitronectin than fibronectin receptor(s). In contrast, GRDGdSP, which has a much higher affinity for the fibronectin receptor (than the vitronectin receptors), had no effect on resorption at similar concentrations in any resorption system used. In summary, the data presented in this paper show that peptides with RGD motifs are capable of inhibiting osteoclastic resorption in bone organ cultures. Our studies not only support the hypothesis concerning the importance of alpha v beta 3 in osteoclastic resorption but also suggest an important role of integrin(s) in events preceding the actual resorption of calcified matrix by osteoclasts. Topics: Amino Acid Sequence; Animals; Bone Resorption; Calcium; Dose-Response Relationship, Drug; Female; Integrins; Intercellular Signaling Peptides and Proteins; Mice; Oligopeptides; Organ Culture Techniques; Osteoclasts; Peptides; Pregnancy; Viper Venoms | 1994 |